Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Moolec Science SA Warrant (MLECW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/29/2025: MLECW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -75% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/29/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.32 | 52 Weeks Range 0.01 - 0.07 | Updated Date 06/28/2025 |
52 Weeks Range 0.01 - 0.07 | Updated Date 06/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -21.69% | Return on Equity (TTM) -174.68% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 897815 |
Shares Outstanding - | Shares Floating 897815 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Moolec Science SA Warrant
Company Overview
History and Background
Moolec Science SA is a biotechnology company focused on developing real animal proteins in plants through Molecular Farming. The warrants (MLECW) represent the right to purchase ordinary shares of Moolec Science SA under specific terms.
Core Business Areas
- Molecular Farming: Utilizing plants as bioreactors to produce animal proteins for the food industry.
Leadership and Structure
Information regarding specific leadership details for the warrants is generally not applicable. Leadership focuses on Moolec Science SA as a whole. Organisational structure impacts the shares issued from exercise of the warrants.
Top Products and Market Share
Key Offerings
- GLEAP Technology: Proprietary technology used to express animal proteins in crops. Market share is not directly applicable to the technology itself but relates to the overall success of Moolec's product development efforts. Competitors include companies developing alternative protein sources through cellular agriculture and plant-based methods.
- SPC Soybean: Soybean with porcine collagen for the food industry. Market share data are not available for specific products. Competitors for this include other soy producing companies.
Market Dynamics
Industry Overview
The alternative protein industry is experiencing significant growth, driven by increasing demand for sustainable and ethical food sources.
Positioning
Moolec is positioned as an innovator within the molecular farming segment of the alternative protein industry, attempting to produce animal proteins in plants.
Total Addressable Market (TAM)
The total addressable market for alternative proteins is projected to reach hundreds of billions of dollars. Moolec is positioned to capture a portion of this market through its unique technology.
Upturn SWOT Analysis
Strengths
- Proprietary GLEAP technology
- Novel approach to animal protein production
- Focus on sustainable food solutions
Weaknesses
- Limited commercial product portfolio
- Dependence on regulatory approvals
- High R&D costs
- Low liquidity
Opportunities
- Growing demand for alternative proteins
- Potential partnerships with food companies
- Expansion into new markets
- Increased investor interest in sustainable agriculture
Threats
- Competition from other alternative protein companies
- Regulatory hurdles
- Consumer acceptance of plant-based animal proteins
- Technological advancements by competitors
Competitors and Market Share
Key Competitors
- BEYONDMEAT (BYND)
- IMPOSSIBLE FOODS (Private)
- DSM (DSM.AS)
Competitive Landscape
Moolec faces competition from established players in the alternative protein industry and innovative startups. Its competitive advantage lies in its molecular farming approach.
Growth Trajectory and Initiatives
Historical Growth: Historical growth depends on the share prices MLEC.
Future Projections: Future growth of the warrants is tied to the projections and performance of Moolec Science SA.
Recent Initiatives: Focus on scaling production capabilities and securing regulatory approvals for key products.
Summary
Moolec Science SA Warrant's value is intrinsically linked to the potential success of Moolec Science SA. Its molecular farming technology is novel, yet faces challenges in scaling production and gaining regulatory approvals. The company operates in a growing market, but competition is fierce. Potential investors need to carefully evaluate the risks and opportunities associated with MLEC as the warrants are derivatively exposed to these forces.
Similar Stocks
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Industry Reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Invest at your own risk.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Moolec Science SA Warrant
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2023-01-03 | CEO - | ||
Sector Healthcare | Industry Biotechnology | Full time employees - | Website https://moolecscience.com |
Full time employees - | Website https://moolecscience.com | ||
Moolec Science SA operates as a science-based food ingredient company. The company is based in Grand Cayman, Cayman Islands.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.